Histological vascular invasion is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type

被引:6
作者
Wang, Hua [1 ,2 ,3 ]
Li, Pengfei [1 ,2 ,3 ]
Zhang, Xinke [1 ,3 ,4 ]
Xia, Zhongjun [1 ,2 ,3 ]
Lu, Yue [1 ,2 ,3 ]
Huang, Huiqiang [1 ,3 ,5 ]
机构
[1] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510060, Guangdong, Peoples R China
[2] Sun Yat Sen Univ, Ctr Canc, Dept Hematol Oncol, 651 Dong Feng Rd East, Guangzhou 510060, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Guangzhou 510060, Guangdong, Peoples R China
[4] Sun Yat Sen Univ, Ctr Canc, Dept Pathol, Guangzhou 510060, Guangdong, Peoples R China
[5] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510060, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
extranodal natural killer/T-cell lymphoma; nasal type; immunohistochemistry; vascular invasion; distant metastasis; prognosis; TUMOR-ASSOCIATED MACROPHAGES; T-CELL; CLINICOPATHOLOGICAL FEATURES; CLINICAL-SIGNIFICANCE; L-ASPARAGINASE; STAGE IE; EXPRESSION; CARCINOMA; CHEMOTHERAPY; CYCLOPHOSPHAMIDE;
D O I
10.3892/ol.2016.4691
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Extranodal natural killer (NK)/T-cell lymphoma, (ENKTL), nasal type, is an aggressive lymphoma with no validated prognostic parameters, to date. In the present study, vascular invasion by this tumor was retrospectively analyzed in 214 patients with untreated ENKTL to evaluate its association with clinical features, treatment response and prognosis. Histological vascular invasion by the tumor was confirmed in 32.7% of patients with ENKTL. The presence of vascular invasion significantly correlated with poor performance status, B symptoms, extranodal involved sites, advanced stage, elevated serum lactate dehydrogenase, D-dimer and cluster of differentiation 68(+) tumor-associated macrophages. Upon treatment termination, the complete remission (CR) rate and overall response rate were significantly lower for the vascular invasion group compared with the non-vascular invasion group. Furthermore, vascular invasion resulted in significantly reduced 5-year progression-free survival (PFS; 21.8 vs. 60.1%) and overall survival (OS; 36.8 vs. 77.0%) rates. Using the multivariate Cox regression model, vascular invasion, stage III/IV and CR after chemotherapy were independent prognostic factors for OS and PFS. Thus, histological vascular invasion by the tumor affected the response to treatment, and was also an independent prognostic factor for OS and PFS in ENKTL, nasal type, suggesting a role for vascular invasion in disease progression.
引用
收藏
页码:825 / 836
页数:12
相关论文
共 40 条
[1]   The inflammatory micro-environment in tumor progression: The role of tumor-associated macrophages [J].
Allavena, Paola ;
Sica, Antonio ;
Solinas, Graziella ;
Porta, Chiara ;
Mantovani, Alberto .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2008, 66 (01) :1-9
[2]   Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years [J].
Au, WY ;
Ma, SY ;
Chim, CS ;
Choy, C ;
Loong, F ;
Lie, AKW ;
Lam, CCK ;
Leung, AYH ;
Tse, E ;
Yau, CC ;
Liang, R ;
Kwong, YL .
ANNALS OF ONCOLOGY, 2005, 16 (02) :206-214
[3]   Expression of the granzyme B inhibitor PI9 predicts outcome in nasal NK/T cell lymphoma:: results of a Western series of 48 patients treated with first-line polychemotherapy within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials [J].
Bossard, Celine ;
Belhadj, Karim ;
Reyes, Felix ;
Martin-Garcia, Nadine ;
Berger, Francoise ;
Kummer, Jean Alain ;
Briere, Josette ;
Baglin, Anne-Catherine ;
Cheze, Stephane ;
Bosq, Jacques ;
Ribrag, Vincent ;
Gisselbrecht, Christian ;
Mounier, Nicolas ;
Gaulard, Philippe .
BLOOD, 2007, 109 (05) :2183-2189
[4]  
Chau Gar-Yang, 2003, Surg Oncol Clin N Am, V12, P25, DOI 10.1016/S1055-3207(02)00077-7
[5]   Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas [J].
Cheson, BD ;
Horning, SJ ;
Coiffier, B ;
Shipp, MA ;
Fisher, RI ;
Connors, JM ;
Lister, TA ;
Vose, J ;
Grillo-López, A ;
Hagenbeek, A ;
Cabanillas, F ;
Klippensten, D ;
Hiddemann, W ;
Castellino, R ;
Harris, NL ;
Armitage, JO ;
Carter, W ;
Hoppe, R ;
Canellos, GP .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (04) :1244-1253
[6]  
CONILL C, 1990, CANCER-AM CANCER SOC, V65, P1864, DOI 10.1002/1097-0142(19900415)65:8<1864::AID-CNCR2820650832>3.0.CO
[7]  
2-U
[8]   Sinonasal lymphoma - A clinicopathologic analysis of 58 cases from the Massachusetts General Hospital [J].
Cuadra-Garcia, I ;
Proulx, GM ;
Wu, CL ;
Wang, CC ;
Pilch, BZ ;
Harris, NL ;
Ferry, JA .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1999, 23 (11) :1356-1369
[9]  
Hong J, 2012, INT J CLIN EXP PATHO, V5, P939
[10]   Absolute lymphocyte count is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type [J].
Huang, J. J. ;
Jiang, W. Q. ;
Lin, T. Y. ;
Huang, Y. ;
Xu, R. H. ;
Huang, H. Q. ;
Li, Z. M. .
ANNALS OF ONCOLOGY, 2011, 22 (01) :149-155